Maravai LifeSciences Holdings Inc - Class A — Cash Flow (NASDAQ:MRVI) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities 368.57 M535.98 M126.22 M7.46 M-57.57 M -57.57 M Cash from investing activities 105.66 M-267.61 M-122.31 M-24.32 M-31.41 M -31.41 M Cash from financing activities -159.05 M-187.5 M-61.09 M-235.71 M-16.5 M -16.5 M Free cash flow 353.72 M518.89 M60.67 M-23.69 M-70.72 M -70.72 M

Nouvelles

Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-02-26

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Maravai T4 2025 : retour à un EBITDA positif grâce aux réductions de coûts

Maravai Q4 2025 slides: return to positive EBITDA on cost cuts

Maravai Lifesciences earnings beat by $0.03, revenue topped estimates

Maravai LifeSciences génère un rendement de 60% après l’alerte de juste valeur en mars

Maravai LifeSciences delivers 60% return after March fair value alert

Maravai Lifesciences à Jefferies : Focus sur la restructuration stratégique

Maravai Lifesciences at Jefferies: Strategic Restructuring Focus

Stifel abaisse l’objectif de prix de l’action Maravai LifeScience après des résultats trimestriels décevants

Stifel lowers Maravai LifeScience stock price target on weak Q3 results

Maravai Lifesciences T3 2025 : Chiffre d’affaires en baisse malgré les progrès de restructuration